Torsadogenic potential of a novel remyelinating drug clemastine for multiple sclerosis assessed in the rabbit proarrhythmia model

We assessed the torsadogenic effects of a novel remyelinating drug clemastine for multiple sclerosis using an in vivo proarrhythmia model of acute atrioventricular block rabbit, since the drug has been demonstrated to suppress the human ether-á-go-go related gene (hERG) K+ channels. Bradycardia was...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों: Satoshi Kawakami, Yoshinobu Nagasawa, Mihoko Hagiwara-Nagasawa, Kensuke Omura, Megumi Aimoto, Akira Takahara
स्वरूप: लेख
भाषा:English
प्रकाशित: Elsevier 2020-11-01
श्रृंखला:Journal of Pharmacological Sciences
विषय:
ऑनलाइन पहुंच:http://www.sciencedirect.com/science/article/pii/S1347861320300839